- Home
- DTM vs PCVX Comparison
DTM vs PCVX Comparison
Compare DTM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTM
- PCVX
- Stock Information
- Founded
- DTM 2021
- PCVX 2013
- Country
- DTM United States
- PCVX United States
- Employees
- DTM N/A
- PCVX N/A
- Industry
- DTM Oil & Gas Production
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- DTM Utilities
- PCVX Health Care
- Exchange
- DTM Nasdaq
- PCVX Nasdaq
- Market Cap
- DTM 9.5B
- PCVX 9.6B
- IPO Year
- DTM N/A
- PCVX 2020
- Fundamental
- Price
- DTM $96.95
- PCVX $30.65
- Analyst Decision
- DTM Buy
- PCVX Strong Buy
- Analyst Count
- DTM 12
- PCVX 9
- Target Price
- DTM $103.17
- PCVX $136.50
- AVG Volume (30 Days)
- DTM 1.4M
- PCVX 3.7M
- Earning Date
- DTM 04-29-2025
- PCVX 05-07-2025
- Dividend Yield
- DTM 3.43%
- PCVX N/A
- EPS Growth
- DTM N/A
- PCVX N/A
- EPS
- DTM 3.60
- PCVX N/A
- Revenue
- DTM $981,000,000.00
- PCVX N/A
- Revenue This Year
- DTM $22.53
- PCVX N/A
- Revenue Next Year
- DTM $7.82
- PCVX N/A
- P/E Ratio
- DTM $26.93
- PCVX N/A
- Revenue Growth
- DTM 6.40
- PCVX N/A
- 52 Week Low
- DTM $61.01
- PCVX $27.66
- 52 Week High
- DTM $114.50
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- DTM 54.09
- PCVX 26.64
- Support Level
- DTM $84.45
- PCVX $28.58
- Resistance Level
- DTM $96.73
- PCVX $32.72
- Average True Range (ATR)
- DTM 4.75
- PCVX 3.75
- MACD
- DTM 0.44
- PCVX 0.12
- Stochastic Oscillator
- DTM 83.54
- PCVX 29.09
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.